Skip to main content

Peer Review reports

From: Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes

Original Submission
28 May 2018 Submitted Original manuscript
14 Jun 2018 Author responded Author comments - Patricia McLaughlin
Resubmission - Version 2
14 Jun 2018 Submitted Manuscript version 2
9 Sep 2018 Reviewed Reviewer Report - Alvin Munsamy
17 Sep 2018 Reviewed Reviewer Report - Sarah Atkinson
23 Oct 2018 Author responded Author comments - Patricia McLaughlin
Resubmission - Version 3
23 Oct 2018 Submitted Manuscript version 3
1 Dec 2018 Reviewed Reviewer Report - Sarah Atkinson
14 Dec 2018 Reviewed Reviewer Report - Alvin Munsamy
8 Jan 2019 Author responded Author comments - Patricia McLaughlin
Resubmission - Version 4
8 Jan 2019 Submitted Manuscript version 4
17 Jan 2019 Author responded Author comments - Patricia McLaughlin
Resubmission - Version 5
17 Jan 2019 Submitted Manuscript version 5
Publishing
18 Jan 2019 Editorially accepted
28 Jan 2019 Article published 10.1186/s12886-019-1044-y

You can find further information about peer review here.

Back to article page